You are here
TGA reforms: A blueprint for TGA's future
Promotion of therapeutic products
Current arrangements for the promotion of therapeutic products
The professional relationship between health care practitioners and therapeutic goods companies is governed by industry and professional codes of conduct, not by government regulation.
A number of therapeutic goods industry associations have codes of conduct/practice which include guidelines on ethical and responsible business practices.
From time to time, examples are highlighted of industry offering inducements to health professionals to promote products. This has the potential to influence clinical decisions on grounds other than the best interests of the patient. Strong and enforceable industry codes of conduct are effective in limiting unethical behaviour, but there needs to be consistency across industry codes in terms of their requirements, application, enforcement and penalties. Concerns have also been raised that non-members of industry associations may not be bound by industry codes.
Progress to 31 December 2014
Progress in implementing the Blueprint recommendations is provided in TGA Reforms: A blueprint for TGA's future Progress Report as at 31 December 2014. This report provides details of progress against the 48 recommendations to be implemented by the TGA during the four year program.
Responsibility for delivering the 18 recommendations relating to the promotion of therapeutic goods lies with the Best Practice Regulation and De-regulation Division of the Department of Health.